Sunil Kadam

Sunil Kadam is an accomplished regulatory and quality compliance professional with extensive experience in the pharmaceutical sector. Currently serving as the Chief Regulatory, Quality & Compliance Officer at Apollo Therapeutics, Sunil has previously held key positions such as Senior Vice President of Global Regulatory Affairs at both Madrigal Pharmaceuticals and Telix Pharmaceuticals Limited, and Therapeutic Area Lead for Global Regulatory Affairs in Rare Disease at Takeda. Sunil has also worked as a consultant at Merit Regulatory Services. Educationally, Sunil holds a degree as an Alberta Heritage Foundation Fellow in Molecular Genetics from the University of Calgary and furthered studies at the Massachusetts Institute of Technology from 1984 to 1986.